EBITDA Margin Expansion and EPS Growth
Despite lower sales, adjusted EBITDA margins expanded by 220 basis points, reflecting transformational savings and improved operational efficiency. Adjusted EPS in the quarter was $0.43, up 3.7% from the prior year.
Successful Cost Management at IDS
The company spent 60% less at IDS compared to 2023, yet sales results exceeded those of 2023, demonstrating effective cost management and innovation.
Growth in Imaging and Wellspect Healthcare
Imaging performed well with growth across all regions. Wellspect Healthcare also delivered growth across all geographies, driven by new product introductions and solid execution.
Positive Performance in Germany
Germany delivered its third consecutive quarter of growth, primarily driven by the Connected Technology Solutions segment.
DS Core Ecosystem Expansion
The DS Core ecosystem surpassed 42,000 unique users, with over 50,000 connected devices, processing more than 100,000 lab orders each month.